Hsu Raymond M, Chan David Y, Siegelman Stanley S
Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, 601 N Caroline St., Baltimore, MD 21287, USA.
AJR Am J Roentgenol. 2004 Mar;182(3):551-7. doi: 10.2214/ajr.182.3.1820551.
Our goal was to correlate the size of renal cell carcinoma with tumor stage, nuclear grade, and histologic subtype in patients treated using partial or radical nephrectomy.
We retrospectively reviewed 213 consecutive renal cell carcinomas resected at our institution from 1995 through 1999. Three groups of lesions stratified by size (< or = 3 cm, > 3-5 cm, > 5 cm) were compared with regard to pathologic findings. Statistical significance was assessed using Fisher's exact test.
Of 50 lesions 3 cm or smaller, 19 (38%) had extension outside the renal capsule (T3 or T4) and 14 (28%) were a high nuclear grade (Fuhrman grade 3 or 4). Lesions 3 cm or smaller and those greater than 3 cm to 5 cm did not differ statistically with regard to T stage or nuclear grade. Lesions larger than 5 cm showed a statistically higher T stage (p < 0.001) and nuclear grade (p = 0.001) than the other smaller lesions. More non-clear cell tumors were found in the two groups of smaller lesions (p = 0.105) but without statistical significance. The majority (58%) of the tumors were asymptomatic and had been detected incidentally on cross-sectional imaging. Lesions larger than 5 cm were significantly more likely to be symptomatic (p < 0.001). Seventy-nine percent of the tumors 3 cm or smaller were incidental, and these lesions did not differ significantly from the symptomatic lesions with regard to stage, grade, or histology.
In our study population, renal cell carcinomas up to 3 cm, including asymptomatic lesions, showed a significant incidence of high nuclear grade and tumor extension beyond the renal capsule; these findings support aggressive management of small lesions. Symptomatic status was not an adequate discriminator to guide management. A longitudinal study is necessary to further evaluate the efficacy of current patterns of therapy.
我们的目标是在接受部分或根治性肾切除术的患者中,将肾细胞癌的大小与肿瘤分期、核分级和组织学亚型进行关联分析。
我们回顾性分析了1995年至1999年在本机构连续切除的213例肾细胞癌。根据大小(≤3cm、>3 - 5cm、>5cm)将病变分为三组,并比较其病理结果。采用Fisher精确检验评估统计学意义。
在50个3cm及以下的病变中,19个(38%)有肾包膜外侵犯(T3或T4期),14个(28%)为高核分级(Fuhrman 3级或4级)。3cm及以下的病变与大于3cm至5cm的病变在T分期或核分级方面无统计学差异。大于5cm的病变在T分期(p < 0.001)和核分级(p = 0.001)方面比其他较小病变有统计学上更高的发生率。在两组较小病变中发现更多的非透明细胞肿瘤(p = 0.105),但无统计学意义。大多数肿瘤(58%)无症状,是在横断面成像时偶然发现的。大于5cm的病变更有可能出现症状(p < 0.001)。3cm及以下的肿瘤中有79%是偶然发现的,这些病变在分期、分级或组织学方面与有症状的病变无显著差异。
在我们的研究人群中,3cm及以下的肾细胞癌,包括无症状病变,显示出高核分级和肿瘤侵犯超出肾包膜的显著发生率;这些发现支持对小病变采取积极的处理措施。症状状态不是指导治疗的充分鉴别因素。有必要进行纵向研究以进一步评估当前治疗模式的疗效。